-+ 0.00%
-+ 0.00%
-+ 0.00%
EBR Systems' WiSE Device Reduces QRS Duration by 26% in 100-Patient US Study
Share
Listen to the news
EBR Systems' WiSE Device Reduces QRS Duration by 26% in 100-Patient US Study
  • EBR Systems reported improved ventricular electrical synchronization with its WiSE system in 100 patients across 31 US centers.
  • No patient showed worsening electrical activation time. Outcomes were similar across two electrode locations, potentially supporting flexibility in placement.
  • Results were presented at the Asia Pacific Heart Rhythm Society Scientific Sessions, held October 21-24, 2026, in Busan, Korea.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EBR Systems Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610270800BIZWIRE_USPR_____20261027_BW072423) on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending